Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
Business Wire•09/10/2026•16:30 ET
0
Key Highlights
- ➤Q3 revenue $7.82 million, down from $7.83 million year over year
- ➤Q3 net income $1.27 million, up from $749,000 year over year
- ➤Q3 diluted EPS $0.16, up from $0.09 year over year
- ➤Cryo-Cell stores more than 250,000 cord blood and tissue specimens
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
Cryo-Cell International, Inc. (NYSE American, Symbol: CCEL) (the “Company”, “Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2026.
Get started
Create a free account to read the full story.